A detailed history of Blueprint Investment Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Blueprint Investment Partners LLC holds 2,015 shares of MRK stock, worth $200,391. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,015
Previous 11,896 83.06%
Holding current value
$200,391
Previous $1.47 Million 84.51%
% of portfolio
0.05%
Previous 0.36%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $1.1 Million - $1.27 Million
-9,881 Reduced 83.06%
2,015 $228,000
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $165,273 - $177,501
1,335 Added 12.64%
11,896 $1.47 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $722,244 - $841,577
6,378 Added 152.47%
10,561 $1.39 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $310,457 - $337,852
-3,099 Reduced 42.56%
4,183 $456,000
Q3 2023

Nov 15, 2023

SELL
$102.95 - $114.33 $460,701 - $511,626
-4,475 Reduced 38.06%
7,282 $749,000
Q2 2023

Aug 15, 2023

SELL
$108.61 - $118.38 $386,760 - $421,551
-3,561 Reduced 23.25%
11,757 $1.36 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $278,143 - $310,351
-2,702 Reduced 14.99%
15,318 $1.63 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $89,800 - $115,136
1,027 Added 6.04%
18,020 $2 Million
Q3 2022

Nov 09, 2022

BUY
$84.53 - $94.96 $227,216 - $255,252
2,688 Added 18.79%
16,993 $1.46 Million
Q2 2022

Aug 09, 2022

BUY
$83.49 - $94.64 $881,236 - $998,925
10,555 Added 281.47%
14,305 $1.3 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $276,691 - $310,153
-3,764 Reduced 50.09%
3,750 $308,000
Q4 2021

Feb 15, 2022

BUY
$72.28 - $90.54 $345,281 - $432,509
4,777 Added 174.53%
7,514 $575,000
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $200,293 - $227,034
2,737 New
2,737 $227,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Blueprint Investment Partners LLC Portfolio

Follow Blueprint Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueprint Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueprint Investment Partners LLC with notifications on news.